CDHR2 antibody (AA 151-250) (Cy3)

Catalog No. ABIN2178337

Product Details anti-CDHR2 Antibody (Cy3)

Target: CDHR2 (Cadherin-Related Family Member 2 (CDHR2))

Binding Specificity: AA 151-250

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This CDHR2 antibody is conjugated to Cy3

Application: Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Predicted Reactivity: Human,Mouse,Rat,Pig

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human PCLKC

Isotype: IgG

Application Details

Application Notes: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Expiry Date: 12 months

Target Details for CDHR2

Target: CDHR2 (Cadherin-Related Family Member 2 (CDHR2))

Alternative Name: Pclkc (CDHR2 Products)

Synonyms: PCDH24 antibody, PCLKC antibody, cadherin related family member 2 antibody, CDHR2 antibody

Background:

Synonyms: FLJ20124, FLJ20383, MGC163154, PC LKC,PC-LKC, Protocadherin LKC.

Background: PCLKC (Protocadherin LKC) belongs to the protocadherin gene family, a subgroup of the cadherin superfamily. It is predominantly expressed in liver, kidney and colon tissues, and has a role in contact inhibition at the lateral surface of epithelial cells. It is a candidate tumor suppressor.